(MENAFN- EIN Presswire)
Chronic obstructive pulmonary disease (COPD) Market
Chronic obstructive pulmonary disease (COPD) market Insights: Rising prevalence of COPD due to aging and smoking.
US, NY, UNITED STATES, January 14, 2025 /EINPresswire / -- Market Research Future Latest
industry Insights on“Chronic obstructive pulmonary disease (COPD) Market Research By CPOD Type (Emphysema, Chronic Bronchitis), By
treatment Type (Drugs, Anti-Inflammatory Drugs, Surgery, Oxygen Therapy), By End Users (Hospitals & Clinics, Homecare Settings, and Others), Industry Size, Top Companies Growth Analysis, Technology, Trends And by Region- Forecast Till 2032”
Chronic Obstructive Pulmonary Disease (COPD) Market share valued at 20.84 billion US$ in 2023 and future growth projected from 22.07 billion US$ in 2024 to 33.72 billion US$ by 2032, at a astonishing CAGR of 4.82% during forecast period (2024 - 2032).
Chronic obstructive pulmonary disease (COPD) Market Insights: Rising prevalence of COPD due to aging and smoking. Focus on innovative drug therapies and non-invasive monitoring. AI-based spirometry, biologics for severe cases, and wearable monitoring devices.
The healthcare landscape in 2025 is poised for a transformative shift, driven by innovation and collaboration. Breakthroughs like genomics-based prevention, AI-powered diagnostics, and physical solutions promise a future of care that is more personalized, proactive, and accessible. By adopting these advancements, healthcare systems across the globe can empower clinicians and establish a sustainable framework for future generations.
Also, Advancements in 3D printing for custom implants and smart implants with IoT integration are gaining traction. Minimally invasive surgery techniques are driving adoption.
Key Companies in the Chronic Obstructive Pulmonary Disease Treatment (COPD) market includes
AstraZeneca (UK)
Abbott Laboratories (US)
Dr. Reddy's Laboratories Ltd (India)
GlaxoSmithKline (UK)
Hoffmann-La Roche Ltd (Switzerland)
Almirall (Spain)
Boehringer Ingelheim (Germany)
Pfizer Inc. (US)
Novartis AG (Switzerland)
Astellas Pharma (Japan), and among others
🔍 Sample Copy of the Report @
As genetic diagnosis and treatment evolve from the cellular level to clinical practice, the information and tools available to clinicians are expected to expand dramatically over the next decade. Advances in less invasive imaging, such as computer-assisted diagnosis of coronary artery disease through combined modalities like echocardiography, magnetic resonance imaging, and positron emission tomography, will enhance outcomes and enable quicker recovery through catheter-based treatments.
Authenticated data presented in the Chronic obstructive pulmonary disease (COPD) Market report is based on findings of extensive primary and secondary research. On the basis of historic growth analysis and the current scenario of the market, the report intends to offer actionable insights and an outlook on global/regional market growth projections. The Chronic obstructive pulmonary disease (COPD) Market report considers the revenue generated from the sales of this report and technologies by various application segments and browses market data tables. Various market parameters such as macroeconomic conditions, market environment, government policies, and competitive landscape are thoroughly studied and taken into account while analysing the market.
Chronic obstructive pulmonary disease (COPD) Market Detailed Segmentation:
Chronic Obstructive Pulmonary Disease Treatment (COPD) Market Segmentation
Chronic Obstructive Pulmonary Disease Treatment (COPD) Type Outlook
Emphysema
Chronic Bronchitis
Chronic Obstructive Pulmonary Disease Treatment (COPD) Treatment Type Outlook
Drugs
Bronchodilator Monotherapy
Short-Acting Beta2-Agonists (SABAs)
Long-Acting Beta2-Agonists (LABAs)
Anti-Inflammatory Drugs
Oral And Inhaled Corticosteroids
Anti-Leukotrienes
Surgery
Lung Volume Reduction Surgery (LVRS)
Lung Transplant
Bullectomy
Others
Oxygen Therapy
Chronic Obstructive Pulmonary Disease Treatment (COPD) End User Outlook
Hospitals & Clinics
Homecare Settings
Others
Chronic Obstructive Pulmonary Disease Treatment (COPD) Regional Outlook
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
🛒 You Can Purchase Complete Report @
Additionally, innovations like DNA chip technology and genetic fingerprinting will significantly improve risk assessment, allowing other technologies to further extend life. However, these advancements will also bring forth a range of new ethical challenges that will need to be addressed thoughtfully.
Key Inquiries Addressed in this Chronic obstructive pulmonary disease (COPD) Market Report include:
📈 How the size of the Chronic obstructive pulmonary disease (COPD) Market will improve in 2025, and what is the projected value by 2034?
📈 The Chronic obstructive pulmonary disease (COPD) Market report provides a quantitative analysis of the current market and estimations through 2025-2032 that assists in identifying the prevailing market opportunities to capitalize on
📈 New strategies offer optimal opportunities for growth maximization in the business
📈 Recent trends are shaping the Chronic obstructive pulmonary disease (COPD) Market
📈 the report provides detailed information related to key drivers, restraints, and opportunities and their impact on the market.
📈 The study comprises a deep dive analysis of the market trend including the current and future trends for depicting the prevalent investment pockets in the market
📈 The report incorporates a competitive analysis of the market players along with their market share in the global market.
📈 The SWOT analysis and Porter's Five Forces model is elaborated in the study of Chronic obstructive pulmonary disease (COPD) Market.
📈 Value chain analysis in the market study provides a clear picture of the stakeholders' roles.
The Chronic obstructive pulmonary disease (COPD) Market report also delves into the competitive landscape, key players, trade patterns, industry value chain, recent news, policies, and regulations. Should you have any inquiries or require customization options, please don't hesitate to contact us.
Other Trending Industry Reports:
Hypnotherapy Industry Outlook 2025 -
Malaria Vaccine Industry Outlook 2025 -
Respiratory Infectious Disease Diagnostics Industry Outlook 2025 -
Rnai Drug Delivery Industry Outlook 2025 -
Bio-Acoustics Sensing Industry Outlook 2025 -
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. The MRFR team have a supreme objective to provide the optimum quality market research and intelligence services for our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Sagar kadam
WantStats Research And Media Pvt. Ltd.
+ +1 (855) 661-4441
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN14012025003118003196ID1109086979